peter sharkey

More Generic Zantac Recalls Over Possible Contamination

More Generic Zantac Recalls Over Possible Contamination

Recalls of generic Zantac believed to be contaminated by a carcinogen continue to flood in. Two other firms have declared recalls of ranitidine heartburn meds in 150 mg and 300 mg doses. The news arrived even as the degree of the drug returns increased with Mylan’s impromptu recall of three lots of nizatidine capsules last week because the API in them also held dangerous levels of NDMA.

Why Companies Recalled Heartburn Medications

Why Companies Recalled Heartburn Medications

Shortly after the Federal officials announced the voluntary recalls of some pharmacies over NDMA, a drug filled with a potential human carcinogen, many other pharmacies have recalled the common variety of heartburn drug Zantac, called ranitidine, from shelves.

Zantac Generics Recall Grows Due to Cancer Risk

Zantac Generics Recall Grows Due to Cancer Risk

Additional generic editions of Zantac are being taken down from pharmacy shelves after officials detected low levels of a possible carcinogens in the heartburn medication.

Stryker Hip Implant Failures

Stryker Hip Implant Failures

The Stryker Tritanium Acetabular Shell, which restores the human hip socket, is built from a titanium alloy covered with a unique kind of porous foam. The foam enables bone cells to bind with it and grow, thereby increasing joint stability. However, a 2018 report in the journal Arthroplasty Today by doctors at NYU Langone Orthopedic Hospitals described five hip implant failures related to Stryker’s Tritanium cups between 2011 and 2016.

Stryker Recalls Femoral Head Implants

Stryker Recalls Femoral Head Implants

Medical technology giant, Stryker Corporation, has issued an urgent voluntary recall of its femoral head implants due to evidence that they may cause serious medical issues.